학술논문
A brief overview of the diabetic neuropathies.
Document Type
Academic Journal
Author
Boulton AJM; Professor of Medicine, University of Manchester, Division of Diabetes, Endocrinology and Gastroenterology , Consultant Physician, Manchester Royal Infirmary, Visiting Professor of Medicine, University of Miami, Miami, FL, USA; President, Worldwide Initiative for Diabetes Education Immediate Past-President, International Diabetes Federation Past-President, European Association for the Study of Diabetes, United States. Electronic address: ABoulton@med.miami.edu.
Source
Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8508335 Publication Model: Print Cited Medium: Internet ISSN: 1872-8227 (Electronic) Linking ISSN: 01688227 NLM ISO Abbreviation: Diabetes Res Clin Pract Subsets: MEDLINE
Subject
Language
English
Abstract
The diabetic neuropathies represent the commonest long-term complications of diabetes, and may be the presenting feature of Type 2 diabetes. In clinical practice, distal symmetrical polyneuropathy (DSPN) and the autonomic neuropathies are the most frequently seen forms of diabetic neuropathy. The 2017 American Diabetes Association classification system for the neuropathies of diabetes are in general use. Treatment challenges remain and the need for revised recommendations and further discussion of management of severely painful DSPN that does not fully respond to conventional medical management is clear, especially in light of the recent opioid crisis in the USA.
Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [Andrew Boulton has been consultant for Advanced Oxygen Therapy, Inc. and a speaker for Advanced Oxygen Therapy, Inc., Nevro, Novo Nordisk, and Pfizer.].
(Copyright © 2023. Published by Elsevier B.V.)
Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [Andrew Boulton has been consultant for Advanced Oxygen Therapy, Inc. and a speaker for Advanced Oxygen Therapy, Inc., Nevro, Novo Nordisk, and Pfizer.].
(Copyright © 2023. Published by Elsevier B.V.)